BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 25923777)

  • 21. Excretion of bisphenol A-glucuronide into the small intestine and deconjugation in the cecum of the rat.
    Sakamoto H; Yokota H; Kibe R; Sayama Y; Yuasa A
    Biochim Biophys Acta; 2002 Nov; 1573(2):171-6. PubMed ID: 12399027
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Weak activity of UDP-glucuronosyltransferase toward Bisphenol analogs in mouse perinatal development.
    Yabusaki R; Iwano H; Tsushima S; Koike N; Ohtani N; Tanemura K; Inoue H; Yokota H
    J Vet Med Sci; 2015 Nov; 77(11):1479-84. PubMed ID: 26074487
    [TBL] [Abstract][Full Text] [Related]  

  • 23. An investigation of systemic exposure to bisphenol AF during critical periods of development in the rat.
    Waidyanatha S; Collins BJ; Cunny H; Aillon K; Riordan F; Turner K; McBride S; Betz L; Sutherland V
    Toxicol Appl Pharmacol; 2021 Jan; 411():115369. PubMed ID: 33338515
    [TBL] [Abstract][Full Text] [Related]  

  • 24. NTP Toxicology and Carcinogenesis Studies of 1-Amino-2,4-Dibromoanthraquinone (CAS No. 81-49-2) in F344/N Rats and B6C3F1 Mice (Feed Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1996 Aug; 383():1-370. PubMed ID: 12692653
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Disposition and metabolism of the new hypocholesterolemic compound S-8921 in rats and dogs.
    Yamaguchi T; Nakajima Y; Mizobuchi M; Inazawa K; Kanazu T; Kadono K; Ohkawa T; Iwatani K
    Arzneimittelforschung; 1998 Oct; 48(10):995-1006. PubMed ID: 9825117
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Biotransformation of bisphenol AF to its major glucuronide metabolite reduces estrogenic activity.
    Li M; Yang Y; Yang Y; Yin J; Zhang J; Feng Y; Shao B
    PLoS One; 2013; 8(12):e83170. PubMed ID: 24349450
    [TBL] [Abstract][Full Text] [Related]  

  • 27. 2,4,6-Tribromophenol Disposition and Kinetics in Rodents: Effects of Dose, Route, Sex, and Species.
    Knudsen GA; Trexler AW; Richards AC; Hall SM; Hughes MF; Birnbaum LS
    Toxicol Sci; 2019 May; 169(1):167-179. PubMed ID: 30768125
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Metabolism and disposition of [(14)C]dimethylamine borane in male Harlan Sprague Dawley rats following gavage administration, intravenous administration and dermal application.
    Mathews JM; Watson SL; Patel PR; Black SR; Hong Y; Levine KE; Ross G; Germolec DR; Thakur SA; Waidyanatha S
    Xenobiotica; 2014 Jan; 44(1):36-47. PubMed ID: 23786350
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Species difference of metabolic clearance of bisphenol A using cryopreserved hepatocytes from rats, monkeys and humans.
    Kurebayashi H; Okudaira K; Ohno Y
    Toxicol Lett; 2010 Oct; 198(2):210-5. PubMed ID: 20599483
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Distribution and preliminary exposure assessment of bisphenol AF (BPAF) in various environmental matrices around a manufacturing plant in China.
    Song S; Ruan T; Wang T; Liu R; Jiang G
    Environ Sci Technol; 2012 Dec; 46(24):13136-43. PubMed ID: 23151244
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Disposition and metabolism of sulfolane in Harlan Sprague Dawley rats and B6C3F1/N mice and in vitro in hepatocytes from rats, mice, and humans.
    Waidyanatha S; Black SR; Blystone CR; Patel PR; Watson SL; Snyder RW; Fennell TR
    Xenobiotica; 2020 Apr; 50(4):442-453. PubMed ID: 31184953
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Metabolism and kinetics of bisphenol a in humans at low doses following oral administration.
    Völkel W; Colnot T; Csanády GA; Filser JG; Dekant W
    Chem Res Toxicol; 2002 Oct; 15(10):1281-7. PubMed ID: 12387626
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Metabolism of bisphenol a in primary cultured hepatocytes from mice, rats, and humans.
    Pritchett JJ; Kuester RK; Sipes IG
    Drug Metab Dispos; 2002 Nov; 30(11):1180-5. PubMed ID: 12386122
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparative toxicokinetics of bisphenol S and bisphenol AF in male rats and mice following repeated exposure via feed.
    Waidyanatha S; Black SR; Croutch CR; Collins BJ; Silinski MAR; Kerns S; Sutherland V; Robinson VG; Aillon K; Fernando RA; Mutlu E; Fennell TR
    Xenobiotica; 2021 Feb; 51(2):210-221. PubMed ID: 32985913
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacokinetics, protein binding and metabolic profile of 3H-icometasone enbutate following intravenous, oral and intratracheal administrations to Sprague-Dawley rats.
    Duchêne P; Giudicelli MD; Neau B; Gronfier A; Firmin Y; Villax P; Saivin S; Houin G
    Arzneimittelforschung; 1998 Apr; 48(4):371-8. PubMed ID: 9608879
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Studies on electrochemical oxidation of estrogenic disrupting compound bisphenol AF and its interaction with human serum albumin.
    Wang X; Yang J; Wang Y; Li Y; Wang F; Zhang L
    J Hazard Mater; 2014 Jul; 276():105-11. PubMed ID: 24866560
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Metabolism and disposition of [14C]BMS-690514 after oral administration to rats, rabbits, and dogs.
    Hong H; Su H; Sun H; Allentoff A; Ekhato IV; Chando T; Caceres-Cortes J; Roongta V; Iyer RA; Humphreys WG; Christopher LJ
    Drug Metab Dispos; 2010 Jul; 38(7):1189-201. PubMed ID: 20363952
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparative metabolism of radiolabeled muraglitazar in animals and humans by quantitative and qualitative metabolite profiling.
    Zhang D; Wang L; Raghavan N; Zhang H; Li W; Cheng PT; Yao M; Zhang L; Zhu M; Bonacorsi S; Yeola S; Mitroka J; Hariharan N; Hosagrahara V; Chandrasena G; Shyu WC; Humphreys WG
    Drug Metab Dispos; 2007 Jan; 35(1):150-67. PubMed ID: 17062777
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Biotransformation of [14C]dasatinib: in vitro studies in rat, monkey, and human and disposition after administration to rats and monkeys.
    Christopher LJ; Cui D; Li W; Barros A; Arora VK; Zhang H; Wang L; Zhang D; Manning JA; He K; Fletcher AM; Ogan M; Lago M; Bonacorsi SJ; Humphreys WG; Iyer RA
    Drug Metab Dispos; 2008 Jul; 36(7):1341-56. PubMed ID: 18420785
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Disposition of tris(4-chlorophenyl)methanol and tris(4-chlorophenyl)methane in male and female Harlan Sprague Dawley rats and B6C3F1/N mice following oral and intravenous administration.
    Catlin NR; Waidyanatha S; Black SR; Mathews JM; Snyder RW; Patel PR; Watson SL; Fennell TR
    Xenobiotica; 2019 Apr; 49(4):484-494. PubMed ID: 29659319
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.